Our clients' sucess stories Fresenius Medical Care
Fresenius Medical Care
Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure.
Fresenius care for more than 333,000 patients in its global network of more than 3,900 dialysis clinics. All in all, it operates 42 production sites on all continents and provides dialysis products such as dialysis machines, dialyzers and related disposables. Around 3.4 million patients with this disease worldwide regularly undergo dialysis treatment at Fresenius. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.
Fresenius is the world’s leading provider of dialysis products and services and its R&D teams continuously research new technical possibilities and further enhancing therapies.
How we helped:
Translation Language Pair:
German to English
English to Simplified Chinese (Mandarin)
Volume: 90 pages
in Schweinfurt and Bad Homburg (Germany) and R&D sites in St. Wendel (Germany), Bucharest (Romania) and Krems (Austria). In the U.S Physicians work side by side on cost-effective dialysis systems for for people with chronic kidney failure.
VEQTA translated and edited medical reports on:
• Risk assessment Reports (e.g Evaluating residual risk)
• Medical Device Equipment Documents (e.g injection moulding Plasma transportation)
• Reports on Monitoring venous / arterial pressure packing material
• Market-ready products documentation.
• Business operations material in emerging markets (e.g Deciding on the implementation of measures)
Innovative product medical product ranges and its development may have R&D decentralized teams such in the case of Fresenius Medical Care. The market conditions in some of the countries where such products are localized vary considerably. VEQTA Translations work with our clients to take such disparity into account when localizing our clients differentiated product range
Such companies may be vertically integrated, meaning its employees in the R&D department also benefit from direct access to the opinions and experience of patients and experts at its own dialysis centres making it of utmost important to have a reliable translation readily available.